163 related articles for article (PubMed ID: 9868032)
1. [Clinical evaluation of polyamine assay in diagnosis of malignant ascites].
Peng A; Zhao S; Zhang X; Zhang G
Hunan Yi Ke Da Xue Xue Bao; 1997; 22(1):59-62, 65. PubMed ID: 9868032
[TBL] [Abstract][Full Text] [Related]
2. Role of fibronectin in diagnosis of malignant ascites.
Sood A; Moudgil A; Sood N; Kharay AS; Kaushal S; Narang AP
J Assoc Physicians India; 1997 Apr; 45(4):283-5. PubMed ID: 12521085
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of ascitic fluid cholesterol as a marker for malignant ascites.
Rana SV; Babu SG; Kocchar R
Med Sci Monit; 2005 Mar; 11(3):CR136-42. PubMed ID: 15735567
[TBL] [Abstract][Full Text] [Related]
4. Ascitic fluid cholesterol in malignant and tubercular ascites.
Sood A; Garg R; Kumar R; Chhina RS; Arora S; Gupta R; Bhatia KL
J Assoc Physicians India; 1995 Nov; 43(11):745-7. PubMed ID: 8773030
[TBL] [Abstract][Full Text] [Related]
5. (1)H NMR spectroscopy of ascitic fluid: discrimination between malignant and benign ascites and comparison of the results with conventional methods.
Bala L; Sharma A; Yellapa RK; Roy R; Choudhuri G; Khetrapal CL
NMR Biomed; 2008 Jul; 21(6):606-14. PubMed ID: 18205245
[TBL] [Abstract][Full Text] [Related]
6. [Genesis of fibronectin in ascites--detection of cellular and plasma fibronectin in portal and malignant ascites].
Rieder H; Ramadori G; Meyer zum Büschenfelde KH
Z Gastroenterol; 1991 Jan; 29(1):16-21. PubMed ID: 2058224
[TBL] [Abstract][Full Text] [Related]
7. Utility of ascitic fluid analysis in patients with malignancy-related ascites.
Salerno F; Restelli B; Incerti P; Annoni G; Capozza L; Badalamenti S; Lampertico P; Mojana E; Moser P; Tommasini M
Scand J Gastroenterol; 1990 Mar; 25(3):251-6. PubMed ID: 1690913
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic laparoscopy, serum CA125, and peritoneal metastasis in gastric cancer.
Fujimura T; Kinami S; Ninomiya I; Kitagawa H; Fushida S; Nishimura G; Kayahara M; Shimizu K; Ohta T; Miwa K
Endoscopy; 2002 Jul; 34(7):569-74. PubMed ID: 12170412
[TBL] [Abstract][Full Text] [Related]
9. Fibronectin, cholesterol and triglycerides ascitic fluid concentration in the prediction of malignancy.
Colloredo Mels G; Bellati G; Auriemma L; Perani C; Leandro G; Vacca N; Pinna N; Alfieri G; Ideo G
Ital J Gastroenterol; 1991 May; 23(4):179-86. PubMed ID: 1661195
[TBL] [Abstract][Full Text] [Related]
10. The importance of serum and ascites fluid alpha-fetoprotein, carcinoembryonic antigen, CA 19-9, and CA 15-3 levels in differential diagnosis of ascites etiology.
Sari R; Yildirim B; Sevinc A; Bahceci F; Hilmioglu F
Hepatogastroenterology; 2001; 48(42):1616-21. PubMed ID: 11813585
[TBL] [Abstract][Full Text] [Related]
11. Ascites in the state of Qatar: aetiology and diagnostic value of ascitic fluid analysis.
Khan FY
Singapore Med J; 2007 May; 48(5):434-9. PubMed ID: 17453102
[TBL] [Abstract][Full Text] [Related]
12. [Biochemical markers of the tumor origin of ascites].
Romette J; di Costanzo-Dufetel J
Pathol Biol (Paris); 1989 Jun; 37(6):720-4. PubMed ID: 2780109
[TBL] [Abstract][Full Text] [Related]
13. Ascitic fluid cholesterol in differential diagnosis of ascites.
Garg R; Sood A; Arora S; Bhatia KL; Chawla AS; Gupta R; Chawla LS
J Assoc Physicians India; 1993 Oct; 41(10):644-6. PubMed ID: 8294324
[TBL] [Abstract][Full Text] [Related]
14. Clinical value of tumour markers and serum-ascites albumin gradient in the diagnosis of malignancy-related ascites.
Chen SJ; Wang SS; Lu CW; Chao Y; Lee FY; Lee SD; Wu SL; Cherng KL; Lo KJ
J Gastroenterol Hepatol; 1994; 9(4):396-400. PubMed ID: 7948823
[TBL] [Abstract][Full Text] [Related]
15. Carcinoembryonic antigen gradients between plasma and malignant ascites: use in detecting peritoneal and liver metastases.
Loewenstein MS; Rittgers RA; Kupchik HZ; Zamcheck N
J Natl Cancer Inst; 1981 May; 66(5):803-6. PubMed ID: 6939926
[TBL] [Abstract][Full Text] [Related]
16. [Immunological parameters in the differential diagnosis of ascites secondary to peritoneal carcinomatosis, hepatic cirrhosis, and congestive heart failure].
Roldan-Molina F; de Oliveira e Silva A; dos Santos TE; Genzini T; de Miranda MP; de Oliveira RM; Santo GC; D'Albuquerque LA
Arq Gastroenterol; 1992; 29(2):56-61. PubMed ID: 1284885
[TBL] [Abstract][Full Text] [Related]
17. Comparative proteomic analysis of human malignant ascitic fluids for the development of gastric cancer biomarkers.
Jin J; Son M; Kim H; Kim H; Kong SH; Kim HK; Kim Y; Han D
Clin Biochem; 2018 Jun; 56():55-61. PubMed ID: 29654727
[TBL] [Abstract][Full Text] [Related]
18. [Detection of polyamines by a new enzymatic differential assay. (8) Studies on tissue polyamine concentrations in patients with genitourinary malignant diseases].
Koide T; Sakai S; Kawada Y; Hara A; Sawada H
Hinyokika Kiyo; 1990 Oct; 36(10):1109-16. PubMed ID: 2264538
[TBL] [Abstract][Full Text] [Related]
19. Telomerase assay for differentiating between malignancy-related and nonmalignant ascites.
Tangkijvanich P; Tresukosol D; Sampatanukul P; Sakdikul S; Voravud N; Mahachai V; Mutirangura A
Clin Cancer Res; 1999 Sep; 5(9):2470-5. PubMed ID: 10499621
[TBL] [Abstract][Full Text] [Related]
20. Study of biochemical parameters of ascitic fluid in exudative ascites with special reference to tuberculous peritonitis.
Bandyopadhyay R; Bandyopadhyay SK; Ghosal J; Kumar U; Dutta A
J Indian Med Assoc; 2006 Apr; 104(4):174, 176-7, 185. PubMed ID: 16910322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
